{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T18:44:12Z","timestamp":1769971452164,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","heartrhythmjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.hrthm.2015.11.040","type":"journal-article","created":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T13:08:34Z","timestamp":1449234514000},"page":"661-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Reduction over time of QTc prolongation in patients with sotalol after cardioversion of atrial fibrillation"],"prefix":"10.1016","volume":"13","author":[{"given":"Hanna","family":"Lenhoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00f6rje","family":"Darp\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Ferber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e5rten","family":"Rosenqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Frick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2015.11.040_bib1","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/CIR.0b013e318290826d","article-title":"Management of patients with atrial fibrillation (compilation of 2006 ACCF\/AHA\/ESC and 2011 ACCF\/AHA\/HRS recommendations): a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"127","author":"Wann","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2015.11.040_bib2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jacc.2006.03.051","article-title":"Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy","volume":"48","author":"Singh","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib3","doi-asserted-by":"crossref","first-page":"15D","DOI":"10.1016\/S0002-9149(02)03375-1","article-title":"Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials","volume":"91","author":"Naccarelli","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCEP.108.824789","article-title":"Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses","volume":"2","author":"Calkins","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/pace.12586","article-title":"Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillation","volume":"38","author":"Agusala","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0735-1097(00)00693-8","article-title":"Use of metoprolol CR\/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study","volume":"36","author":"Kuhlkamp","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib7","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation\u2014developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2015.11.040_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/eurheartj\/14.suppl_H.88","article-title":"Antiarrhythmic drugs and torsade de pointes","volume":"14","author":"Lazzara","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2015.11.040_bib9","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0002-9149(91)90191-M","article-title":"Reverse use-dependent effects of sotalol demonstrated by recording monophasic action potentials of the right ventricle","volume":"68","author":"Schmitt","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib10","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/CIRCULATIONAHA.111.080887","article-title":"Clinical and genetic determinants of torsade de pointes risk","volume":"125","author":"Sauer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2015.11.040_bib11","doi-asserted-by":"crossref","first-page":"212178","DOI":"10.1100\/2012\/212178","article-title":"Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review","volume":"2012","author":"Kallergis","year":"2012","journal-title":"ScientificWorld Journal"},{"key":"10.1016\/j.hrthm.2015.11.040_bib12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1540-8159.1998.tb00148.x","article-title":"Taking the \u201cidio\u201d out of \u201cidiosyncratic\u201d: predicting torsades de pointes","volume":"21","author":"Roden","year":"1998","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib13","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1540-8159.1998.tb00150.x","article-title":"Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective study","volume":"21","author":"Houltz","year":"1998","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib14","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0735-1097(95)00286-5","article-title":"Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine","volume":"26","author":"Hohnloser","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib15","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0735-1097(99)00226-0","article-title":"Exaggerated QT prolongation after cardioversion of atrial fibrillation","volume":"34","author":"Choy","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib16","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ahj.2007.01.040","article-title":"Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes","volume":"153","author":"Gupta","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2015.11.040_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cjca.2010.11.001","article-title":"Dorian P. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management","volume":"27","author":"Gillis","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/0091270007311921","article-title":"Performance characteristics for some typical QT study designs under the ICH E-14 guidance","volume":"48","author":"Hutmacher","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1540-8167.2006.00408.x","article-title":"Zareba W. QT interval: how to measure it and what is \u201cnormal\u201d","volume":"17","author":"Goldenberg","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1540-8167.2010.01738.x","article-title":"Preferred QT correction formula for the assessment of drug-induced QT interval prolongation","volume":"21","author":"Chiladakis","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib21","series-title":"Modern Applied Statistics with S","author":"Venables","year":"2002"},{"key":"10.1016\/j.hrthm.2015.11.040_bib22","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/ndt\/gft226","article-title":"Glomerular filtration rate-estimating equations for patients with advanced chronic kidney disease","volume":"28","author":"Evans","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.hrthm.2015.11.040_bib23","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jacc.2007.09.066","article-title":"Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome","volume":"51","author":"Darbar","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib24","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.amjcard.2013.06.027","article-title":"Correlation of QT interval correction methods during atrial fibrillation and sinus rhythm","volume":"112","author":"Musat","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib25","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/j.1540-8159.1993.tb01821.x","article-title":"Serum electrolytes and catecholamines after cardioversion from ventricular tachycardia and atrial fibrillation","volume":"16","author":"Salerno","year":"1993","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/0002-9149(92)91211-L","article-title":"Changes in plasma concentrations of atrial natriuretic peptides after cardioversion of chronic atrial fibrillation","volume":"70","author":"Arakawa","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/hrt.32.1.57","article-title":"Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation","volume":"32","author":"Hartel","year":"1970","journal-title":"Br Heart J"},{"key":"10.1016\/j.hrthm.2015.11.040_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/clc.4960170410","article-title":"Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports","volume":"17","author":"Faber","year":"1994","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hrthm.2015.11.040_bib29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/pgmj.68.798.289","article-title":"Sotalol-induced torsade de pointes: management with magnesium infusion","volume":"68","author":"Arstall","year":"1992","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.hrthm.2015.11.040_bib30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/CIRCULATIONAHA.107.758672","article-title":"Feedback remodeling of cardiac potassium current expression: a novel potential mechanism for control of repolarization reserve","volume":"118","author":"Xiao","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2015.11.040_bib31","doi-asserted-by":"crossref","unstructured":"Edvardsson N, Aunes M, Frison L, Berggren AR. Inverse correlation between the atrial fibrillatory rate and the ventricular repolarization time: observations at baseline and after an intravenous infusion of a combined potassium and sodium current blocker [published online ahead of print August 5, 2015]. Ann Noninvasive Electrocardiol. doi:10.1111\/anec.12300.","DOI":"10.1111\/anec.12300"},{"key":"10.1016\/j.hrthm.2015.11.040_bib32","doi-asserted-by":"crossref","first-page":"H198","DOI":"10.1152\/ajpheart.00726.2014","article-title":"Dynamics of AV coupling during human atrial fibrillation: role of atrial rate","volume":"309","author":"Mase","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527115015131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527115015131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T21:25:56Z","timestamp":1718227556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527115015131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1547527115015131"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2015.11.040","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction over time of QTc prolongation in patients with sotalol after cardioversion of atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2015.11.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}